Gene Query: STRIP2

Dataset Description Geneva Score
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 51.62
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 51.62
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 49.71
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 39.81
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 36.95
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 33.06
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 32.77
Ebola virus (EBOV) infection of ARPE-19 cells 32.43
Characterization of parental and rociletinib-resistant derived H1975 cell lines 30.45
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 29.28
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 28.33
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 26.52
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 26.52
Identification of global regulators of T-helper cell lineage specification 25.4
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 25.4
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 24.37
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 23.31
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 20.31
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 20.05
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 20.02
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 19.29
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 19.13
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 18.6
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 18.56
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 18.45
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 18.45
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 18.44
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 18.41
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 18.41
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 18.14
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 17.47
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 17.42
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 17.15
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 17.15
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 16.95
Transcriptome analysis of U87 cells upon LINC00152 knockdown 16.77
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 16.08
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 15.98
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 15.97
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 15.7
Primary human trophoblast from term placenta 15.39
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 15.28
Cleavage Factor Im as a key regulator of 3’ UTR length 15.22
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 15.11
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 14.56
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 14.48
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 14.39
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 14.08
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 13.97
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 13.74
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 13.67
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 13.55
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 13.32
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 13.21
Developmental stage specific chromosome architecture in human erythroid cells 13.21
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 13.14
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 12.18
RNA-seq of resting and activated CD4+ T cells +-JQ1 11.73
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 11.52
RNA-Seq in PWS iPSC-derived neurons 11.45
Gene expression in PANC1 cells treated with Rakicidin 11.43
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 11.36
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 11.03
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 11.03
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 10.94
Transcriptome profiling of 5 human adenocarcinoma cell lines 10.87
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 10.86
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 10.72
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 10.67
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 10.45
Analysis of transcriptional regulation by Myt1 and Myt1l 10.41
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 10.37
Genome-wide discovery of human splicing branchpoints 10.35
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 10.33
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 10.26
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 10.19
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 9.99
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 9.94
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 9.87
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.75
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 9.75
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 9.74
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 9.73
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 9.63
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 9.62
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 9.41
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 9.4
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 9.33
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 9.32
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 9.11
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 9.11
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 9.05
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 8.98
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 8.98
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.97
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.97
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 8.94
Spliceosomal disruption of the non-canonical BAF complex in cancer 8.92
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 8.82
Transcriptome of human white and brown adipose tissue biopsies 8.8
Transcriptomes in healthy and CHB fetal hearts 8.78
Inhibition of TNBC metastasis by Gpx1 8.71
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 8.68
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 8.66
Impact on erythroid progenitor type on erythroid differntiation 8.53
Selective suppression of endothelial cytokine production by progesterone receptor 8.52
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 8.52
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 8.43
Dynamic reorganization of nuclear architecture during human cardiogenesis 8.39
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 8.39
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 8.37
IRF2 is a master regulator of human keratinocyte stem cell fate 8.37
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 8.32
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 8.32
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 8.31
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 8.31
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 8.2
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 8.18
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 8.11
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 8.09
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 8.0
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 7.99
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 7.95
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 7.94
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 7.94
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 7.91
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 7.78
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 7.7
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 7.59
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 7.49
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 7.45
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 7.45
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 7.39
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 7.38
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 7.3
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 7.25
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 7.21
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 7.21
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 7.21
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 7.1
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 7.08
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 7.05
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 7.05
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 7.05
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 6.93
RNA-seq analysis of BAP1-depleted uveal melanoma cells 6.88
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 6.88
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 6.83
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 6.81
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 6.81
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 6.74
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 6.71
Molecular analysis of renal cell carcinoma with unclassfied histology 6.66
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 6.66
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 6.62
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 6.58
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 6.58
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 6.54
Accurate annotation of human protein-coding small open reading frames 6.54
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 6.51
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 6.47
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 6.42
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 6.38
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.3
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 6.28
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 6.19
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 6.15
Short and Long RNA sequencing of human mature erythrocytes 6.12
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.11
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 6.11
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 6.11
CHD1 regulates cell fate determination by activation of differentiation-induced genes 6.09
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 6.07
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 6.01
RNA sequencing of GlyH-101-treated MCF-7 cell line 5.97
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.93
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 5.9
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 5.9
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 5.88
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 5.86
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 5.49
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 5.49
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 5.49
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 5.49
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 5.4
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 5.4
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 5.39
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 5.39
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 5.36
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 5.35
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 5.25
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 5.22
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 5.19
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 5.17
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 5.13
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 5.09
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.06
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.06
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 5.05
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.02
Gene Expression Profiling of SPOP Knocked Down Cell 5.0
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 4.95
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 4.94
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 4.92
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 4.9
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 4.89
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 4.83
Paxillin regulates genomic networks in prostate cancer [PC3] 4.82
Identification of Atrial Fibrillation associated genes and functional non-coding variants 4.81
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 4.79
SLIGRL-induced gene expression changes in NHEK cells 4.78
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 4.76
In situ CAPTURE of chromatin interactions by biotinylated dCas9 4.76
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.75
RNA seq with AML (NB4) cells upon FTO inhibition 4.75
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 4.73
High-Throughput Kinetic Analysis of Fractional Killing 4.58
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 4.56
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 4.49
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 4.49
A transcriptome dataset revealing the molecular features of breast cancer stem cells 4.48
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 4.47
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.47
Epigenomic landscape during organ formation in human early embryos 4.45
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 4.42
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 4.42
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 4.38
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 4.37
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 4.36
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 4.36
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 4.36
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 4.36
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 4.35
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 4.33
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 4.31
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 4.3
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 4.29
A sister of NANOG regulates genes expressed in pre-implantation human development 4.28
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 4.21
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 4.21
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 4.21
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 4.18
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 4.14
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.13
K562 polyA RNA-Seq 4.13
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.12
The pause-initiation limit restricts transcription activation in human cells 4.11
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 4.06
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 4.04
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 4.03
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 4.02
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 4.02
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 4.01
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 3.99
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 3.98
TGF-β regulation of miRNA expression in pancreatic cancer 3.97
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.97
The effect of PPARG inhibition on human angiomyolipoma cells 3.96
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 3.89
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 3.88
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 3.88
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 3.87
Comparing gene expression in iPSC derived RPE from control and AMD donors 3.85
Genome-wide discovery of human splicing branchpoints [RNAse] 3.85
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 3.79
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 3.79
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.74
Genetic-to-epigenetic Therapy for Pancreatic Cancer 3.72
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 3.72
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 3.71
Solid phase chemistry to covalently and reversibly capture thiolated RNA 3.71
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.69
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 3.69
BET bromodomain inhibition 3.69
Generation of KRAS signatures using immortalized isogenic lung cells. 3.68
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 3.63
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.62
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 3.6
The cytokine environment influence on human skin-derived T cells 3.58
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 3.56
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 3.55
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 3.54
Induction of Cardiomyocyte Proliferation [pz-822_human] 3.54
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.51
3.5
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 3.48
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.47
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 3.46
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 3.43
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 3.43
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.41
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 3.4
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 3.39
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.35
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 3.34
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 3.3
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 3.29
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 3.28
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 3.24
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 3.23
Transcriptional responses of melanoma cells to BRAF inhibition 3.23
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 3.22
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 3.19
UV_24h_GRO-Seq 3.18
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.15
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 3.13
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 3.06
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 3.03
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.03
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 3.02
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 3.02
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 3.02
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.98
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.97
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.97
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.97
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 2.96
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 2.96
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.94
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.93
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.91
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.91
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.86
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 2.82
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 2.81
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 2.79
Sensing self and nonself circular RNAs 2.77
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.76
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.76
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 2.68
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 2.6
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 2.6
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 2.6
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 2.59
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.58
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 2.56
Gene expression in GBM with Cav3.2 inhibition 2.55
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 2.52
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 2.5
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 2.5
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.5
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.5
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 2.48
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 2.45
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.44
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.44
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.4
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.4
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.37
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 2.37
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.35
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.35
RNA Sequencing of Human iPS derived Cardiomyocytes 2.35
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.33
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 2.32
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 2.32
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.27
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 2.27
The conserved transcriptional landscapes in human spermatogenesis 2.25
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.24
Transcriptome sequencing of K-562 cells 2.24
RNAseq Analysis in glioblastoma cells treated with Mepazine 2.22
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 2.19
Differential gene expression profiles in imatinib-resistant cell lines 2.17
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 2.16
The transcriptome of Kawasaki Disease arteritis 2.16
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 2.16
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 2.16
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 2.13
RNA-seq analysis of differentiating human erythroblasts 2.11
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.1
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 2.09
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 2.09
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.08
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 2.07
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 2.04
The effect of Abl kinases on non-small cell carcinoma global transcriptome 2.04
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 2.03
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 2.02
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.01
Finding missing proteins from epigenetically manipulated human cells 1.98
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 1.93
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 1.93
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.92
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.91
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 1.88
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 1.87
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 1.87
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 1.86
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.81
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.8
miR-93 Targets in Human Endothelial Cells 1.78
Human Treg IFNg/IL-10 subpopulations 1.78
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.75
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 1.74
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 1.66
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 1.66
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.65
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.65
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.63
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 1.61
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.6
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.59
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 1.59
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.55
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.55
Transcriptomic profiling of human peripheral blood-derived mast cells 1.55
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.55
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.55
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.55
Function and hormonal regulation of GATA3 in human first trimester placentation 1.53
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.52
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.5
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.49
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.46
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.46
Polarized B -cell functions 1.44
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.41
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.4
Downregulation of LATS kinases alters p53 to promote cell migration 1.37
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.37
RNA-sequencing of healthy human skeletal myocytes 1.37
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 1.37
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.32
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.32
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.31
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.26
Effects of transcription on genome - nuclear lamina interactions 1.26
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 1.16
Gene expression changes in human melanoma cell lines compared to primary melanocytes 1.16
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.16
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 1.16
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 1.16
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.16
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.15
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.15
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.14
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 1.13
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 1.03
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.02
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.98
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 0.94
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.93
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 0.92
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.9
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.9
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 0.87
Tyrosine Kinase Inhibitor Cardiotoxicity 0.87
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 0.84
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.81
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 0.81
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.8
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 0.8
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 0.8
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.79
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 0.78
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 0.71
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.66
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.66
Expression and functions of long noncoding RNAs during human T helper cell differentiation 0.65
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.65
The Glioma-Infiltrating T Cell Receptor Repertoire 0.59
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.51
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.51
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.48
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.45
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.43
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.43
Transcriptome-wide response to synthetic chromatin protein PcTF 0.42
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.39
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.39
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.38
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.38
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.36
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.32
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.32
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.32
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.32
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.32
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.3
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.3
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.29
Toxoplasma gondii infection of human retinal pigment epithelial cells 0.25
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.25
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.19
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.18
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.17
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.16
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.14
JAK dependent survival of ALK- ALCL 0.12
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.09
ML29755 RNA-seq data 0.08
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.07
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.06
RNA-Seq of the corpus callosum from 12 individuals 0.06
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.06
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.06
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.06
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.05
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation